This
Australian company had developed a unique camouflage
to visually correct skin conditions. The company had:
No
direct competitors in Australia or overseas A
large, stable market which was identifiable and accessible One
Australian outlet located away from major centres Manual
methods that precluded outsourcing or resellers Gained
wide publicity for which it was unprepared.
Challenge
To develop a strategy to penetrate Australian market that could be implemented with existing company resources,
and could be replicated in global markets.
Solution
We conducted primary and secondary research to verify
local and global market size and value.
We interviewed 92 doctors, specialists, dermatologists
and distribution specialists to gain:
Feedback
on product and interest to refer or sell Recommendations
for best locations/referees for maximum exposure and
acceptance Positioning
for maximum appeal to doctors and patients Recommendations
for most appropriate and acceptable distribution model Knowledge
of key market obstacles and opportunities.
Project
2:
We developed a detailed marketing strategy to penetrate
the local market and to expand globally.
We created sales tools
to:
Capture
and prioritise responses from media Promote
the product cost-effectively at scientific meetings Support
medical positioning of the product for dermatologists
and patients Profile
existing and potential partners and referees.
Outcomes
In 8
weeks the company gained:
Comprehensive
research into size and value of the accessible markets A
detailed review of their methods and ways to optimize
them A
complete marketing strategy including alternative
distribution models Introduction
to the key referees and influencers in NSW and QLD Recommendations
and contacts for optimum distribution points and partners Scripts
and processes to capture and manage media responses Staged
strategy to enable penetration of accessible markets
with existing
resources Detailed
action plans to enable staged rollout nationally and
globally.
Results
At completion of the project, the company was:
poised
for international publicity linked to a major clinical
trial prepared
to capitalize and manage market demand with existing resources attractively
positioned for investment for growth.